| Q45869309 | Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q35576409 | Clinical gene therapy for nonmalignant disease |
| Q35949692 | Current clinical perspectives on myocardial angiogenesis. |
| Q34512167 | Current gene therapy for stomach carcinoma |
| Q36931967 | Current strategies for myocardial gene delivery |
| Q44773869 | Distribution of Intramyocardially injected extracellular MR contrast medium: effects of concentration and volume |
| Q36075155 | Does gene therapy become pharmacotherapy? |
| Q37939775 | Gene delivery methods in cardiac gene therapy |
| Q36786243 | Gene therapy in the treatment of heart failure |
| Q36304278 | Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? |
| Q64378310 | Pluronic Block Copolymers for Gene Delivery |
| Q36293316 | Pluronic block copolymers for gene delivery. |
| Q34565341 | Pluronic block copolymers: novel functional molecules for gene therapy |
| Q45870003 | Pre‐administration of angiopoietin‐1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model |
| Q36081298 | Reappraisal of recent clinical trials of angiogenic therapy in myocardial ischemia |
| Q33541827 | Recombinant human VEGF165b inhibits experimental choroidal neovascularization |
| Q40676331 | Simvastatin stimulates VEGF release via p44/p42 MAP kinase in vascular smooth muscle cells |
| Q37924086 | Stable angina pectoris: antianginal therapies and future directions |
| Q58088756 | Systemic VEGF levels after coronary artery bypass graft surgery reflects the extent of inflammatory response |
| Q35080395 | Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review |
| Q40199219 | Treatment of heart failure by calcium cycling gene therapy |
| Q35116151 | Vascular complications and gene therapy |
| Q34836871 | Virus-based gene delivery systems |